Literature DB >> 3089943

Effect of some proliferative and environmental factors on the toxicity of mitomycin C to tumor cells in vitro.

S Rockwell.   

Abstract

Mitomycin C (MC) was more toxic to EMT6 mouse mammary tumor cells in vitro under hypoxia than under aerobic conditions. This was evidenced both in survival curves defining the toxicity of treatment with a constant dose of MC given for different periods of time and in survival curves defining the effect of a 1-hr treatment with different concentrations of MC. Cultures preincubated for different periods from 1 to 6 hr in hypoxia all had similar MC sensitivities. In contrast, cultures preincubated in hypoxia for 4 hr then "reoxygenated" before MC treatment had the same sensitivities as cultures which had never been hypoxic. This shows that the oxygenation at the time of MC exposure, rather than the preincubation protocol, was the parameter determining cell sensitivity. Exponentially-growing (proliferating) and plateau-phase (quiescent) cultures had similar MC survival curves; neither type of culture repaired potentially lethal damage when held for up to 24 hr in HBSS after MC treatment. The sensitivity of the cells increased as the pH of the culture medium was decreased to low values (pH 7.0-6.0), but extracellular pH had no significant effect on the cytotoxicity of MC over the physiologic range (7.0-7.4). These data suggest that differences in the metabolic characteristics of cells that are hypoxic and aerobic during MC treatment, rather than perturbations of the cell proliferation patterns, the PLDR capacity of the cells, or the extracellular pH during the hypoxic incubation, are responsible for the different sensitivities of aerobic and hypoxic cells to MC in vitro.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3089943     DOI: 10.1002/ijc.2910380213

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

Review 1.  Cellular pharmacology of quinone bioreductive alkylating agents.

Authors:  S Rockwell; A C Sartorelli; M Tomasz; K A Kennedy
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

2.  Modulation of the antineoplastic efficacy of mitomycin C by dicoumarol in vivo.

Authors:  S Rockwell; S R Keyes; A C Sartorelli
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 3.  Modulation of the tumor vasculature and oxygenation to improve therapy.

Authors:  Dietmar W Siemann; Michael R Horsman
Journal:  Pharmacol Ther       Date:  2015-06-11       Impact factor: 12.310

4.  Hypoxia and radiation therapy: past history, ongoing research, and future promise.

Authors:  Sara Rockwell; Iwona T Dobrucki; Eugene Y Kim; S Tucker Marrison; Van Thuc Vu
Journal:  Curr Mol Med       Date:  2009-05       Impact factor: 2.222

5.  Intraaortic stop-flow infusion: pharmacokinetic feasibility study of regional chemotherapy for unresectable gastrointestinal cancers.

Authors:  A M Averbach; O A Stuart; T A Sugarbaker; A D Stephens; V Fernandez-Trigo; F Shamsa; P H Sugarbaker
Journal:  Ann Surg Oncol       Date:  1995-07       Impact factor: 5.344

6.  Preliminary studies with a new hypoxia-selective cytotoxin, KS119W, in vitro and in vivo.

Authors:  Eugene Y Kim; Yanfeng Liu; Oluwatoyin M Akintujoye; Krishnamurthy Shyam; Tina A Grove; Alan C Sartorelli; Sara Rockwell
Journal:  Radiat Res       Date:  2012-08-03       Impact factor: 2.841

7.  Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions.

Authors:  R S Marshall; M C Paterson; A M Rauth
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

Review 8.  The impact of hypoxia and its modification of the outcome of radiotherapy.

Authors:  Michael R Horsman; Jens Overgaard
Journal:  J Radiat Res       Date:  2016-03-16       Impact factor: 2.724

9.  Intraperitoneal photodynamic therapy of the rat CC531 adenocarcinoma.

Authors:  R B Veenhuizen; J P Marijnissen; P Kenemans; M C Ruevekamp-Helmers; L W 't Mannetje; T J Helmerhorst; F A Stewart
Journal:  Br J Cancer       Date:  1996-06       Impact factor: 7.640

10.  Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro.

Authors:  S Koch; F Mayer; F Honecker; M Schittenhelm; C Bokemeyer
Journal:  Br J Cancer       Date:  2003-12-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.